Small peptide analogs to stromal derived factor-1 enhance chemotactic migration of human and mouse hematopoietic cells

Stromal cell-derived factor 1 (SDF-1) is a chemokine that binds to the CXCR4 receptor. Its functions include acting as a chemotactic factor for hematopoietic stem and progenitor cells. We recently reported the synthesis of a small cyclized peptide analog (31 amino acids) of the terminal regions of SDF-1 that had biological function comparable to the native molecule (67 amino acids). In the present study, we investigated the effects of SDF-1 analogs (CTCE0021 and CTCE0214) in the chemotactic migration of peripheral blood hematopoietic cells (lineage-negative and CD34(+) cells). Enhanced chemotaxis of normal and G-CSF-mobilized hematopoietic cells was observed with both SDF-1 analogs in a dose-dependent manner. The increases were statistically significant (p less than or equal to 0.016 by one-way ANOVA) at analog concentrations of 50 to 100 mug/mL. Colony-forming progenitor cells were not affected by exposure to the analogs up to 100 mug/mL. When different doses of the SDF-1 analog CTCE0214 were administered to mice, significant increases in circulating hematopoietic cells (identified by flow cytometry as lineage"(low/-), Sca-1(+), and c-kit(+)) were observed after a single injection of 75 mug per animal. The effect was apparent at 4 hours and became significant at 24 hours. These results suggest that SDF-1 analogs can be considered for mobilization of hematopoietic stem cells. (C) 2004 International Society for Experimental Hematology. Published by Elsevier Inc.